Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials

*Graduate School of Second Clinical Medical College of Nanchang University, Nanchang, China;

†Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China; and

‡Cardiovascular Disease Prevention and Treatment Center, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Correspondence: Qing-hua Wu, MS, Department of Cardiology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Rd, Nanchang 330006, Jiangxi, China (e-mail: [email protected]).

Supported by Innovative Research Group Project of the National Natural Science Foundation of China (No. 82160093).

The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jcvp.org).

S. Yang and W. Shen have contributed equally to the realization of this manuscript and share first authors.

留言 (0)

沒有登入
gif